Mon, May 2, 2022

Joseph Pantginis Maintained (XBIO) at Strong Buy with Decreased Target to $40 on, May 2nd, 2022

Joseph Pantginis of HC Wainwright & Co., Maintained "Xenetic Biosciences, Inc." (XBIO) at Strong Buy with Decreased Target from $50 to $40 on, May 2nd, 2022.

Joseph, nor any peers, have made any analyst calls on XBIO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30